|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Chronic Pancreatitis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Pancreatitis | |||||
| Pancreatitis, Chronic | |||||
| 3 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| Pancreatic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| RG1068 (Synthetic Human Secretin) | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Secretin | |||||
| 6 | More general drug interventions related to this trial | ||||
| Gastrointestinal Agents | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Massachusetts General Hospital | |||||